These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


156 related items for PubMed ID: 24087953

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Association of the genetic markers for myocardial infarction with sudden cardiac death.
    Ivanova AA, Maksimov VN, Orlov PS, Ivanoshchuk DE, Savchenko SV, Voevoda MI.
    Indian Heart J; 2017 Apr; 69 Suppl 1(Suppl 1):S8-S11. PubMed ID: 28400043
    [Abstract] [Full Text] [Related]

  • 3. [Evaluation of association between 9 genetic polymorphism and myocardial infarction in the Siberian population].
    Maksimov VN, Kulikov IV, Orlov PS, Gafarov VV, Maliutina SK, Romashchenko AG, Voevoda MI.
    Vestn Ross Akad Med Nauk; 2012 Apr; (5):24-9. PubMed ID: 22856164
    [Abstract] [Full Text] [Related]

  • 4. Clinical application of chromosome 9p21.3 genotyping in patients with coronary artery disease.
    Nikulina S, Artyukhov I, Shesternya P, Gavrilyuk O, Maksimov V, Voyevoda M, Brusentsov D.
    Exp Ther Med; 2019 Oct; 18(4):3100-3108. PubMed ID: 31572550
    [Abstract] [Full Text] [Related]

  • 5. The association of polymorphic variants, rs2267788, rs1333049 and rs2383207 with coronary artery disease, its severity and presentation in North Indian population.
    Kashyap S, Kumar S, Agarwal V, Misra DP, Rai MK, Kapoor A.
    Gene; 2018 Mar 30; 648():89-96. PubMed ID: 29309886
    [Abstract] [Full Text] [Related]

  • 6. The chromosome 9p21 region and myocardial infarction in a European population.
    Koch W, Türk S, Erl A, Hoppmann P, Pfeufer A, King L, Schömig A, Kastrati A.
    Atherosclerosis; 2011 Jul 30; 217(1):220-6. PubMed ID: 21511257
    [Abstract] [Full Text] [Related]

  • 7. Chromosome 9p21 rs10757278 polymorphism is associated with the risk of metabolic syndrome.
    Bayoglu B, Cakmak HA, Yuksel H, Can G, Karadag B, Ulutin T, Vural VA, Cengiz M.
    Mol Cell Biochem; 2013 Jul 30; 379(1-2):77-85. PubMed ID: 23535969
    [Abstract] [Full Text] [Related]

  • 8. Association of ANRIL polymorphism (rs1333049:C>G) with myocardial infarction and its pharmacogenomic role in hypercholesterolemia.
    Ahmed W, Ali IS, Riaz M, Younas A, Sadeque A, Niazi AK, Niazi SH, Ali SH, Azam M, Qamar R.
    Gene; 2013 Feb 25; 515(2):416-20. PubMed ID: 23266621
    [Abstract] [Full Text] [Related]

  • 9. Synergistic effect of stromelysin-1 (matrix metallo-proteinase-3) promoter 5A/6A polymorphism with smoking on the onset of young acute myocardial infarction.
    Liu PY, Chen JH, Li YH, Wu HL, Shi GY.
    Thromb Haemost; 2003 Jul 25; 90(1):132-9. PubMed ID: 12876636
    [Abstract] [Full Text] [Related]

  • 10. Chromosome 9p21 single nucleotide polymorphisms are not associated with recurrent myocardial infarction in patients with established coronary artery disease.
    Virani SS, Brautbar A, Lee VV, MacArthur E, Morrison AC, Grove ML, Nambi V, Frazier L, Wilson JM, Willerson JT, Boerwinkle E, Ballantyne CM.
    Circ J; 2012 Jul 25; 76(4):950-6. PubMed ID: 22322877
    [Abstract] [Full Text] [Related]

  • 11. Association of polymorphisms on chromosome 9p21.3 region with increased susceptibility of abdominal aortic aneurysm in a Chinese Han population.
    Wei Y, Xiong J, Zuo S, Chen F, Chen D, Wu T, Guo W, Hu Y.
    J Vasc Surg; 2014 Apr 25; 59(4):879-85. PubMed ID: 24365123
    [Abstract] [Full Text] [Related]

  • 12. Polymorphisms in the long non-coding RNA CDKN2B-AS1 may contribute to higher systolic blood pressure levels in hypertensive patients.
    Bayoglu B, Yuksel H, Cakmak HA, Dirican A, Cengiz M.
    Clin Biochem; 2016 Jul 25; 49(10-11):821-7. PubMed ID: 26944720
    [Abstract] [Full Text] [Related]

  • 13. Interaction between MMP-9 gene polymorphisms and smoking in relation to myocardial infarction in a Uighur population.
    Wang L, Ma YT, Xie X, Yang YN, Fu ZY, Li XM, Liu F, Huang Y, Ma X, Chen BD, Yuan S, Sun MH, Peng X, Wang BZ.
    Clin Appl Thromb Hemost; 2012 Jul 25; 18(1):72-8. PubMed ID: 21733941
    [Abstract] [Full Text] [Related]

  • 14. Genetic Variant rs10757278 on Chromosome 9p21 Contributes to Myocardial Infarction Susceptibility.
    Chen G, Fu X, Wang G, Liu G, Bai X.
    Int J Mol Sci; 2015 May 21; 16(5):11678-88. PubMed ID: 26006241
    [Abstract] [Full Text] [Related]

  • 15. Lack of association of two common polymorphisms on 9p21 with risk of coronary heart disease and myocardial infarction; results from a prospective cohort study.
    Dehghan A, van Hoek M, Sijbrands EJ, Oostra BA, Hofman A, van Duijn CM, Witteman JC.
    BMC Med; 2008 Oct 16; 6():30. PubMed ID: 18925945
    [Abstract] [Full Text] [Related]

  • 16. Case-Control Study on the Interaction Effects of rs10757278 Polymorphisms at 9p21 Locus and Traditional Risk Factors on Coronary Heart Disease in Xinjiang, China.
    Lu WH, Zhang WQ, Zhao YJ, Gao YT, Tao N, Ma YT, Liu JW, Wulasihan M.
    J Cardiovasc Pharmacol; 2020 May 16; 75(5):439-445. PubMed ID: 32079855
    [Abstract] [Full Text] [Related]

  • 17. Chromosome 9p21 polymorphism is associated with myocardial infarction but not with clinical outcome in Han Chinese.
    Peng WH, Lu L, Zhang Q, Zhang RY, Wang LJ, Yan XX, Chen QJ, Shen WF.
    Clin Chem Lab Med; 2009 May 16; 47(8):917-22. PubMed ID: 19548844
    [Abstract] [Full Text] [Related]

  • 18. Strong association of the APOA5-1131T>C gene variant and early-onset acute myocardial infarction.
    De Caterina R, Talmud PJ, Merlini PA, Foco L, Pastorino R, Altshuler D, Mauri F, Peyvandi F, Lina D, Kathiresan S, Bernardinelli L, Ardissino D, Gruppo Italiano Aterosclerosi.
    Atherosclerosis; 2011 Feb 16; 214(2):397-403. PubMed ID: 21130994
    [Abstract] [Full Text] [Related]

  • 19. Genome-Wide Association Study for Incident Myocardial Infarction and Coronary Heart Disease in Prospective Cohort Studies: The CHARGE Consortium.
    Dehghan A, Bis JC, White CC, Smith AV, Morrison AC, Cupples LA, Trompet S, Chasman DI, Lumley T, Völker U, Buckley BM, Ding J, Jensen MK, Folsom AR, Kritchevsky SB, Girman CJ, Ford I, Dörr M, Salomaa V, Uitterlinden AG, Eiriksdottir G, Vasan RS, Franceschini N, Carty CL, Virtamo J, Demissie S, Amouyel P, Arveiler D, Heckbert SR, Ferrières J, Ducimetière P, Smith NL, Wang YA, Siscovick DS, Rice KM, Wiklund PG, Taylor KD, Evans A, Kee F, Rotter JI, Karvanen J, Kuulasmaa K, Heiss G, Kraft P, Launer LJ, Hofman A, Markus MR, Rose LM, Silander K, Wagner P, Benjamin EJ, Lohman K, Stott DJ, Rivadeneira F, Harris TB, Levy D, Liu Y, Rimm EB, Jukema JW, Völzke H, Ridker PM, Blankenberg S, Franco OH, Gudnason V, Psaty BM, Boerwinkle E, O'Donnell CJ.
    PLoS One; 2016 Feb 16; 11(3):e0144997. PubMed ID: 26950853
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.